RecruitingPhase 4NCT06576830

Optimization of Pediatric Tonsillectomy to IMprove AnaLgesia

Single-Dose Intraoperative Methadone for Pain Management in Pediatric Tonsillectomy: A Randomized Double Blind Clinical Trial


Sponsor

Duke University

Enrollment

440 participants

Start Date

Nov 21, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

The purpose of this study is to compare the use of short acting opioids (fentanyl/hydromorphone) with long acting opioids (methadone) for pain control following tonsillectomy surgery in children and adolescents.


Eligibility

Min Age: 3 YearsMax Age: 17 Years

Inclusion Criteria5

  • Age \>= 3 and \< 18 years
  • Elective tonsillectomy +/- adenoidectomy
  • Signed informed consent by parent or legal guardian
  • Children \>= 12 years must provide signed written consent, Children \>= 7 years must provide verbal assent
  • Negative pregnancy test within 48 hours for post pubescent females

Exclusion Criteria4

  • History of chronic kidney or liver disease
  • Current diagnosis of a chronic pain disorder
  • Planned admission to the Pediatric Intensive Care Unit (PICU)
  • Additional procedures under general anesthesia for which opioids would be prescribed

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGMethadone

Single-dose intraoperative intravenous methadone with initial dose at 0.15 mg/kg in children and 0.2 mg/kg in adolescents.

DRUGFentanyl/Hydromorphone

Per routine care, given as needed


Locations(1)

Duke University Medical Center

Durham, North Carolina, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06576830


Related Trials